全球神经血管导管市场规模、份额、成长分析，按应用（栓塞性中风、脑动脉瘤）、按类型（微型、球囊）- 2024-2031 年产业预测

Global Neurovascular Catheters Market Size, Share, Growth Analysis, By Application(Embolic Stroke, Brain Aneurysms), By Type(Micro, Balloon) - Industry Forecast 2024-2031

出版日期: 2024年04月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球神经血管导管市场规模为30.3亿美元，预计将从2023年的32.5亿美元成长到2031年的56.6亿美元，预测期间（2024-2031年）复合年增长率为7.20%。

几个重要的驱动因素推动了神经血管市场的发展，包括脑动脉瘤和中风等神经系统疾病的发生率不断上升、不健康生活方式的养成、公众对神经系统疾病治疗的意识增强、可支配收入的增加以及主要市场参与者推出新产品。神经血管疾病的激增以及神经血管导管技术的进步将推动市场扩张。值得注意的是，全球蜘蛛网膜下腔出血（SAH）盛行率为每10万人有6.67人，每年影响超过50万人，其中低收入和中等收入国家承受沉重负担。此外，由于神经血管通路导管的技术突破，市场预计将持续成长。例如，2022年2月，强生医疗器材公司子公司CERENOVUS推出了EMBOGUARD，这是一种用于血管内手术（包括急性缺血性中风介入）的尖端球囊导引导管。随着对不同神经血管通路导管的持续研究和比较研究，市场可能会进一步扩大，例如2022 年9 月的研究强调了内径为0.096 英吋的通路导管对于透过股动脉和桡动脉进行神经血管治疗的功效，证明了技术成功率高，手术併发症极少。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Medtronic plc (Ireland)
Stryker Corporation (US)
Terumo Corporation (Japan)
Penumbra, Inc. (US)
MicroPort Scientific Corporation (China)
Johnson & Johnson (US)
Merit Medical Systems, Inc. (US)
Integer Holdings Corporation (US)
Teleflex Incorporated (US)
Penumbra, Inc. (US)
Rapid Medical Ltd. (Israel)
MicroVention, Inc. (US)
Acandis GmbH (Germany)
Balt Extrusion (France)
Covidien (US)
Boston Scientific Corporation (US)
Cook Medical LLC (US)
Phenox GmbH (Germany)
Stryker Neurovascular (US)
Balt USA LLC (US)
Metactive Medical, Inc. (US)
Amplitude Surgical SA (France)

简介目录

Product Code: SQMIG35A2523

Global Neurovascular Catheters Market size was valued at USD 3.03 Billion in 2022 and is poised to grow from USD 3.25 Billion in 2023 to USD 5.66 Billion by 2031, at a CAGR of 7.20% during the forecast period (2024-2031).

Several significant drivers propel the neurovascular market, including the escalating incidence of neurological disorders like brain aneurysms and stroke, the uptake of unhealthy lifestyles, heightened public consciousness regarding neurological ailment treatment, increasing disposable income, and the introduction of novel products by major market players. The surge in neurovascular diseases alongside advancements in neurovascular catheter technology are poised to fuel market expansion. Notably, the global prevalence of subarachnoid hemorrhage (SAH) stands at 6.67 per 100,000 individuals, affecting over 500,000 people annually, with low- and middle-income countries bearing a substantial burden. Furthermore, market growth is expected to persist due to technological breakthroughs in neurovascular access catheters. For instance, in February 2022, CERENOVUS, a subsidiary of Johnson & Johnson Medical Device Companies, launched EMBOGUARD, a cutting-edge balloon guide catheter for endovascular procedures, including acute ischemic stroke interventions. The market is likely to expand further with ongoing research and comparative studies on different neurovascular access catheters, such as the study in September 2022 highlighting the efficacy of access catheters with an inner diameter of 0.096 inches for neurovascular therapies via both femoral and radial arteries, demonstrating high technical success rates and minimal procedural complications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurovascular Catheters Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Neurovascular Catheters Market Segmental Analysis

Global Neurovascular Catheters Market is segmented on the basis of application, type, end use and region. By type, the market is segmented into micro, balloon, access, embolization, and others. By application, the market is segmented into embolic stroke, brain aneurysms, arteriovenous malformations, and others. By end use, the market is segmented into hospitals, clinics, ambulatory surgical centers, and diagnostic centers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurovascular Catheters Market

The increasing incidence of neurological conditions like stroke, aneurysms, and arteriovenous malformations (AVMs) is fueling the need for neurovascular catheters, which are crucial for both diagnosis and treatment. As the occurrence of these disorders continues to rise, the demand for neurovascular catheters is also escalating accordingly.

Restraints in the Global Neurovascular Catheters Market

Neurovascular catheters are employed for accessing and maneuvering through intricate blood vessels within the brain, presenting challenges that may result in diverse complications including bleeding, clotting, vessel perforation, and infection. These complications pose significant risks, potentially leading to severe neurological impairments or fatality, and contribute to prolonged hospitalization and escalated healthcare expenses. Furthermore, the likelihood of complications is heightened in patients with concurrent medical conditions.

Market Trends of the Global Neurovascular Catheters Market

The rising occurrence of neurological conditions like stroke, aneurysms, and arteriovenous malformations is fueling the need for neurovascular catheters. As per the World Health Organization (WHO), stroke ranks as the second most prevalent cause of death worldwide, intensifying the demand for viable treatment solutions for neurological disorders.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Neurovascular Catheters Market by Application

Market Overview
Embolic Stroke
Brain Aneurysms
Arteriovenous Malformations
Others

Global Neurovascular Catheters Market by Type

Market Overview
Micro
Balloon
Access
Embolization
Others

Global Neurovascular Catheters Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integer Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rapid Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acandis GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt Extrusion (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covidien (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Neurovascular (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt USA LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Metactive Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amplitude Surgical SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments